t(4;14)(p16.3;q32) is strongly associated with a shorter survival in myeloma patients
- PMID: 12492597
- DOI: 10.1046/j.1365-2141.2003.03983_5.x
t(4;14)(p16.3;q32) is strongly associated with a shorter survival in myeloma patients
Comment in
-
FGFR3 dysregulation and clinical outcome in myeloma.Br J Haematol. 2003 Jan;120(1):166. doi: 10.1046/j.1365-2141.2003.03983_1.x. Br J Haematol. 2003. PMID: 12492593 No abstract available.
Comment on
-
FGFR3 dysregulation in multiple myeloma: frequency and prognostic relevance.Br J Haematol. 2002 Jun;117(3):626-8. doi: 10.1046/j.1365-2141.2002.03429.x. Br J Haematol. 2002. PMID: 12028033
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
